Loading... Please wait... Loading... Please wait...
| Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 05/18/2021 | JANE STREET GROUP, LLC | 7,149 | $253,000 | 100.00% | 0.02% |
| 05/17/2021 | MORGAN STANLEY | 670 | $24,000 | -50.70% | 0.00% |
| 04/30/2021 | WEALTHCARE ADVISORY PARTNERS LLC | 375 | $13,000 | 100.00% | 0.00% |
| 05/13/2021 | ADVISOR GROUP HOLDINGS, INC. | 350 | $12,000 | -30.00% | 0.00% |
| 05/17/2021 | TOWER RESEARCH CAPITAL LLC (TRC) | 100 | $4,000 | 100.00% | 0.00% |
| 05/13/2021 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% | 0.00% |
| 05/13/2021 | WOLVERINE ASSET MANAGEMENT LLC | 0 | $0 | -100.00% | 0.00% |
| 05/17/2021 | HRT FINANCIAL LP | 0 | $0 | -100.00% | 0.00% |
| 05/12/2021 | UBS GROUP AG | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 3 institutional investors and hedge funds held shares of NRx Pharmaceuticals, Inc.. The most heavily invested institutionals were:
Bluefin Trading, LLC: 87,900
VERTEX ONE ASSET MANAGEMENT INC.: 100,000
COWEN INC.: 0
A. 0.03% of NRx Pharmaceuticals, Inc. stock is owned by institutional investors.
A. Institutional investors have bought a total of 187,900 shares in the last 24 months. This purchase volume represents approximately $484,782 in transactions.
